VENUTI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 207
EU - Europa 77
AS - Asia 52
AF - Africa 2
OC - Oceania 1
Totale 339
Nazione #
US - Stati Uniti d'America 207
IT - Italia 23
IE - Irlanda 20
SE - Svezia 15
CN - Cina 14
VN - Vietnam 14
SG - Singapore 8
HK - Hong Kong 6
KR - Corea 5
DE - Germania 4
CZ - Repubblica Ceca 3
FR - Francia 3
GR - Grecia 2
NG - Nigeria 2
UA - Ucraina 2
UZ - Uzbekistan 2
AT - Austria 1
AU - Australia 1
CH - Svizzera 1
ES - Italia 1
FI - Finlandia 1
IL - Israele 1
IN - India 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 339
Città #
Chandler 66
Dublin 20
Fairfield 10
Turin 9
Medford 8
Nyköping 7
Ashburn 6
Dong Ket 6
Hangzhou 6
Jacksonville 6
New York 6
Princeton 6
Seoul 5
Singapore 5
Hong Kong 4
San Diego 4
Udine 4
Ann Arbor 3
Boston 3
Cambridge 3
Chengdu 3
Frankfurt am Main 3
Seattle 3
Wilmington 3
Abuja 2
Beijing 2
Brno 2
Hebei 2
Milan 2
Moncalieri 2
San Mateo 2
Woodbridge 2
Canberra 1
Falls Church 1
Guiyang 1
Houston 1
Lappeenranta 1
Los Angeles 1
Madrid 1
Munich 1
Paris 1
Piraeus 1
Saint Petersburg 1
San Jose 1
Tel Aviv 1
Upper Marlboro 1
Vercelli 1
Vienna 1
Villarsiviriaux 1
Vyronas 1
Totale 233
Nome #
Community Pharmacy Practice in Italy during the COVID-19 (SARS-CoV-2) Pandemic: Regulatory Changes and a Cross-Sectional Analysis of Seroprevalence 62
Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients 61
FARMACISTI A RISCHIO CONTAGIO. INDAGINE SIEROLOGICA PIEMONTESE 59
On the SARS-CoV-2 "Variolation Hypothesis": No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary Cases 50
Farmacisti: una popolazione particolarmente esposta? 49
Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases 46
Real-Life Experience of Continuously Infused Ceftolozane/Tazobactam in Patients with Bronchiectasis and Multidrug-Resistant Pseudomonas aeruginosa Infection in the Outpatient Setting 14
18-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with non-tuberculous mycobacterial infections 6
Low azithromycin maximal concentrations in patients concomitantly taking rifampicin: time to move away from rifampicin in the treatment of non-tuberculous mycobacteria? 5
Totale 352
Categoria #
all - tutte 1.775
article - articoli 0
book - libri 0
conference - conferenze 448
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.223


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 4 3 2 14 5 8 20
2021/202284 1 4 4 7 8 4 2 4 0 3 20 27
2022/2023133 13 21 5 22 9 31 6 4 15 1 3 3
2023/202471 9 16 1 2 0 11 4 4 6 1 9 8
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 352